STE · STERIS plc
← all insidersOrthopedic, Prosthetic & Surgical Appliances & Supplies · Listed on NYSE
Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON
Open-market trades2
Distinct insiders2
Bought$0
Sold$1.25M
Net flow$-1.25M
Recent filings
How to read this
- Filed
- Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
- Ticker
- The issuer's stock symbol. Select it to open that company's insider-activity page.
- Issuer
- The company whose shares were traded.
- Sector
- The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
- Insider
- The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
- Role
- The insider's relationship to the company: director, officer, or 10% owner.
- Code
- SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
- Side
- Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
- 10b5-1
- Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
- Shares
- Number of shares in this transaction.
- Price
- Reported price per share. Blank for grants, gifts, and other trades with no stated price.
- Value
- Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
- Owned after
- Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
- Own Δ
- How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
- Co. Δ
- Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
- D/I
- Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
- Lag
- Days from the trade date to the filing date (Form 4 is due within 2 business days).
Transaction codes
Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.
- P
- Open market or private purchase of non-derivative or derivative security
- S
- Open market or private sale of non-derivative or derivative security
- A
- Grant, award or other acquisition pursuant to Rule 16b-3(d)
- D
- Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
- F
- Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
- M
- Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
- G
- Bona fide gift
- C
- Conversion of derivative security
- X
- Exercise of in-the-money or at-the-money derivative security
- J
- Other acquisition or disposition (describe transaction)
| Filed ↓Date the Form 4 was filed with the SEC (due within 2 business days of the trade). | Insider | Role | CodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S). | SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼). | Shares | PriceReported price per share. Blank for trades with no stated price. | ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ). | Owned afterShares the insider held (directly or indirectly) immediately after this trade. | Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing. | Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable. | Link to SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Sohi Mohsen | Director | M | ▼ sell | 4,058→ 4,058 Ordinary Shares | — | — | 0 | — | — | filing |
| 2026-08-12 | Sohi Mohsen | Director | A | ▲ buy | 1,229→ 1,229 Ordinary Shares | — | — | 8,979 | — | — | filing |
| 2026-08-12 | Sohi Mohsen | Director | A | ▲ buy | 1,099→ 1,099 Ordinary Shares | — | — | 1,099 | — | — | filing |
| 2026-08-12 | Sohi Mohsen | Director | S | ▼ sell | 4,0580 | $235.78 | $956.8K | 24,305 | −14% | −<0.01% (now 0.02%) | filing |
| 2026-08-12 | Sohi Mohsen | Director | M | ▲ buy | 4,0580 | $86.23 | $349.9K | 28,363 | +17% | +<0.01% (now 0.03%) | filing |
| 2026-08-12 | Shapiro Louis | Director | A | ▲ buy | 1,025→ 1,025 Ordinary Shares | — | — | 2,000 | — | — | filing |
| 2026-08-12 | Shah Nirav R | Director | A | ▲ buy | 512→ 512 Ordinary Shares | — | — | 7,015 | — | — | filing |
| 2026-08-12 | Shah Nirav R | Director | A | ▲ buy | 1,506→ 1,506 Ordinary Shares | — | — | 1,506 | — | — | filing |
| 2026-08-12 | Martin Paul Edward | Director | A | ▲ buy | 512→ 512 Ordinary Shares | — | — | 5,074 | — | — | filing |
| 2026-08-12 | Martin Paul Edward | Director | A | ▲ buy | 1,506→ 1,506 Ordinary Shares | — | — | 1,506 | — | — | filing |
| 2026-08-12 | HOLLAND CHRISTOPHER S | Director | A | ▲ buy | 1,025→ 1,025 Ordinary Shares | — | — | 5,989 | — | — | filing |
| 2026-08-12 | FELDMANN CYNTHIA L | Director | A | ▲ buy | 512→ 512 Ordinary Shares | — | — | 8,640 | — | — | filing |
| 2026-08-12 | FELDMANN CYNTHIA L | Director | A | ▲ buy | 1,506→ 1,506 Ordinary Shares | — | — | 1,506 | — | — | filing |
| 2026-08-12 | Boulud Pierre | Director | A | ▲ buy | 1,025→ 1,025 Ordinary Shares | — | — | 1,392 | — | — | filing |
| 2026-08-12 | Alegria Esther M. | Director | A | ▲ buy | 512→ 512 Ordinary Shares | — | — | 3,408 | — | — | filing |
| 2026-08-12 | Alegria Esther M. | Director | A | ▲ buy | 1,506→ 1,506 Ordinary Shares | — | — | 1,506 | — | — | filing |
| 2026-07-02 | Sohi Mohsen | Director | M | ▼ sell | 3,781→ 3,781 Ordinary Shares | — | — | 0 | — | — | filing |
| 2026-07-02 | Sohi Mohsen | Director | F | ▼ sell | 1,8370 | $212.30 | $390.0K | 24,305 | −7% | −<0.01% (now 0.02%) | filing |
| 2026-07-02 | Sohi Mohsen | Director | M | ▲ buy | 3,7810 | $71.40 | $270.0K | 26,142 | +17% | +<0.01% (now 0.03%) | filing |
| 2026-06-16 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | S | ▼ sell10b5-1 | 1,4190 | $209.28 | $297.0K | 35,259 | −4% | −<0.01% (now 0.04%) | filing |
| 2026-06-08 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | F | ▼ sell | 4010 | $212.24 | $85.1K | 36,678 | −1% | −<0.01% (now 0.04%) | filing |
| 2026-06-08 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | F | ▼ sell | 650 | $212.24 | $13.8K | 6,194 | −1% | −<0.01% (now <0.01%) | filing |
| 2026-06-08 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | F | ▼ sell | 1950 | $212.24 | $41.4K | 12,257 | −2% | −<0.01% (now 0.01%) | filing |
| 2026-06-08 | Kohler Kenneth E | Officer (SVP & GM, AST) | F | ▼ sell | 1500 | $212.24 | $31.8K | 11,332 | −1% | −<0.01% (now 0.01%) | filing |
| 2026-06-08 | Fraser Mary Clare | Officer (SVP & Chief HRO) | F | ▼ sell | 6000 | $212.24 | $127.3K | 13,716 | −4% | −<0.01% (now 0.01%) | filing |
| 2026-06-08 | Carestio Daniel A | Director, Officer (President and CEO) | S | ▼ sell10b5-1 | 1,3740 | $212.00 | $291.3K | 63,647 | −2% | −<0.01% (now 0.07%) | filing |
| 2026-06-08 | Carestio Daniel A | Director, Officer (President and CEO) | S | ▼ sell10b5-1 | 3,0540 | $214.64 | $655.5K | 65,021 | −4% | −<0.01% (now 0.07%) | filing |
| 2026-06-08 | Carestio Daniel A | Director, Officer (President and CEO) | F | ▼ sell10b5-1 | 1,8890 | $212.24 | $400.9K | 68,075 | −3% | −<0.01% (now 0.07%) | filing |
| 2026-06-08 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | F | ▼ sell | 900 | $212.24 | $19.1K | 13,184 | −0.7% | −<0.01% (now 0.01%) | filing |
| 2026-06-05 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | F | ▼ sell | 3650 | $210.19 | $76.7K | 37,079 | −1.0% | −<0.01% (now 0.04%) | filing |
| 2026-06-05 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | F | ▼ sell | 640 | $210.19 | $13.5K | 6,259 | −1% | −<0.01% (now <0.01%) | filing |
| 2026-06-05 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | F | ▼ sell | 2390 | $210.19 | $50.2K | 12,452 | −2% | −<0.01% (now 0.01%) | filing |
| 2026-06-05 | Kohler Kenneth E | Officer (SVP & GM, AST) | F | ▼ sell | 1840 | $210.19 | $38.7K | 11,482 | −2% | −<0.01% (now 0.01%) | filing |
| 2026-06-05 | Fraser Mary Clare | Officer (SVP & Chief HRO) | F | ▼ sell | 3110 | $210.19 | $65.4K | 14,316 | −2% | −<0.01% (now 0.01%) | filing |
| 2026-06-05 | Carestio Daniel A | Director, Officer (President and CEO) | F | ▼ sell | 2,6190 | $210.19 | $550.5K | 69,964 | −4% | −<0.01% (now 0.07%) | filing |
| 2026-06-05 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | F | ▼ sell | 1900 | $210.19 | $39.9K | 13,274 | −1% | −<0.01% (now 0.01%) | filing |
| 2026-06-04 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | A | ▲ buy | 15,200→ 15,200 Ordinary Shares | — | — | 15,200 | — | — | filing |
| 2026-06-04 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | F | ▼ sell | 2470 | $209.76 | $51.8K | 37,444 | −0.7% | −<0.01% (now 0.04%) | filing |
| 2026-06-04 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | A | ▲ buy | 4,3590 | — | — | 37,691 | +13% | +<0.01% (now 0.04%) | filing |
| 2026-06-04 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | A | ▲ buy | 2,620→ 2,620 Ordinary Shares | — | — | 2,620 | — | — | filing |
| 2026-06-04 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | F | ▼ sell | 410 | $209.76 | $8.6K | 6,323 | −0.6% | −<0.01% (now <0.01%) | filing |
| 2026-06-04 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | A | ▲ buy | 7500 | — | — | 6,364 | +13% | +<0.01% (now <0.01%) | filing |
| 2026-06-04 | McGowan Lindsey | Officer (VP, Chf. Comp. & Quality Offc.) | A | ▲ buy | 4,036→ 4,036 Ordinary Shares | — | — | 4,036 | — | — | filing |
| 2026-06-04 | McGowan Lindsey | Officer (VP, Chf. Comp. & Quality Offc.) | F | ▼ sell | 3290 | $209.76 | $69.0K | 5,656 | −5% | −<0.01% (now <0.01%) | filing |
| 2026-06-04 | McGowan Lindsey | Officer (VP, Chf. Comp. & Quality Offc.) | A | ▲ buy | 1,1550 | — | — | 5,985 | +24% | +<0.01% (now <0.01%) | filing |
| 2026-06-04 | Majors Cary L | Officer (SVP and President, Healthcare) | A | ▲ buy | 16,548→ 16,548 Ordinary Shares | — | — | 16,548 | — | — | filing |
| 2026-06-04 | Majors Cary L | Officer (SVP and President, Healthcare) | F | ▼ sell | 670 | $209.76 | $14.1K | 17,338 | −0.4% | −<0.01% (now 0.02%) | filing |
| 2026-06-04 | Majors Cary L | Officer (SVP and President, Healthcare) | A | ▲ buy | 4,7460 | — | — | 17,405 | +37% | +<0.01% (now 0.02%) | filing |
| 2026-06-04 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | A | ▲ buy | 8,080→ 8,080 Ordinary Shares | — | — | 8,080 | — | — | filing |
| 2026-06-04 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | F | ▼ sell | 1270 | $209.76 | $26.6K | 12,691 | −1.0% | −<0.01% (now 0.01%) | filing |
| 2026-06-04 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | A | ▲ buy | 2,3160 | — | — | 12,818 | +22% | +<0.01% (now 0.01%) | filing |
| 2026-06-04 | Kohler Kenneth E | Officer (SVP & GM, AST) | A | ▲ buy | 7,668→ 7,668 Ordinary Shares | — | — | 7,668 | — | — | filing |
| 2026-06-04 | Kohler Kenneth E | Officer (SVP & GM, AST) | F | ▼ sell | 660 | $209.76 | $13.8K | 11,666 | −0.6% | −<0.01% (now 0.01%) | filing |
| 2026-06-04 | Kohler Kenneth E | Officer (SVP & GM, AST) | A | ▲ buy | 2,1990 | — | — | 11,732 | +23% | +<0.01% (now 0.01%) | filing |
| 2026-06-04 | Fraser Mary Clare | Officer (SVP & Chief HRO) | A | ▲ buy | 10,492→ 10,492 Ordinary Shares | — | — | 10,492 | — | — | filing |
| 2026-06-04 | Fraser Mary Clare | Officer (SVP & Chief HRO) | F | ▼ sell | 5910 | $209.76 | $124.0K | 14,627 | −4% | −<0.01% (now 0.02%) | filing |
| 2026-06-04 | Fraser Mary Clare | Officer (SVP & Chief HRO) | A | ▲ buy | 3,0090 | — | — | 15,218 | +25% | +<0.01% (now 0.02%) | filing |
| 2026-06-04 | Carestio Daniel A | Director, Officer (President and CEO) | A | ▲ buy | 82,740→ 82,740 Ordinary Shares | — | — | 82,740 | — | — | filing |
| 2026-06-04 | Carestio Daniel A | Director, Officer (President and CEO) | F | ▼ sell | 9950 | $209.76 | $208.7K | 72,583 | −1% | −<0.01% (now 0.07%) | filing |
| 2026-06-04 | Carestio Daniel A | Director, Officer (President and CEO) | A | ▲ buy | 23,7360 | — | — | 73,578 | +48% | +0.02% (now 0.08%) | filing |
| 2026-06-04 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | A | ▲ buy | 18,564→ 18,564 Ordinary Shares | — | — | 18,564 | — | — | filing |
| 2026-06-04 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | M | ▼ sell | 660 | $209.76 | $13.8K | 13,464 | −0.5% | −<0.01% (now 0.01%) | filing |
| 2026-06-04 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | A | ▲ buy | 5,3250 | — | — | 13,530 | +65% | +<0.01% (now 0.01%) | filing |
| 2026-06-04 | Breeden Richard C | Director | M | ▼ sell | 3,781→ 3,781 Ordinary Shares | — | — | 0 | — | — | filing |
| 2026-06-04 | Breeden Richard C | Director | S | ▼ sell | 1,4810 | $209.51 | $310.3K | 38,964 | −4% | −<0.01% (now 0.04%) | filing |
| 2026-06-04 | Breeden Richard C | Director | M | ▲ buy | 3,7810 | $71.40 | $270.0K | 40,445 | +10% | +<0.01% (now 0.04%) | filing |
| 2026-06-04 | Boulud Pierre | Director | A | ▲ buy | 367→ 367 Ordinary Shares | — | — | 367 | — | — | filing |
| 2026-06-03 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | F | ▼ sell | 3370 | — | — | 33,332 | −1% | −<0.01% (now 0.03%) | filing |
| 2026-06-03 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | F | ▼ sell | 810 | — | — | 5,614 | −1% | −<0.01% (now <0.01%) | filing |
| 2026-06-03 | McGowan Lindsey | Officer (VP, Chf. Comp. & Quality Offc.) | F | ▼ sell | 1980 | — | — | 4,830 | −4% | −<0.01% (now <0.01%) | filing |
| 2026-06-03 | Majors Cary L | Officer (SVP and President, Healthcare) | F | ▼ sell | 7680 | — | — | 12,659 | −6% | −<0.01% (now 0.01%) | filing |
| 2026-06-03 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | F | ▼ sell | 2080 | — | — | 10,502 | −2% | −<0.01% (now 0.01%) | filing |
| 2026-06-03 | Kohler Kenneth E | Officer (SVP & GM, AST) | F | ▼ sell | 1090 | — | — | 9,533 | −1% | −<0.01% (now <0.01%) | filing |
| 2026-06-03 | Fraser Mary Clare | Officer (SVP & Chief HRO) | F | ▼ sell | 6730 | — | — | 12,209 | −5% | −<0.01% (now 0.01%) | filing |
| 2026-06-03 | Carestio Daniel A | Director, Officer (President and CEO) | F | ▼ sell | 1,2540 | — | — | 49,842 | −2% | −<0.01% (now 0.05%) | filing |
| 2026-06-03 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | F | ▼ sell | 990 | — | — | 8,205 | −1% | −<0.01% (now <0.01%) | filing |
Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.